Hypospadias and genes related to genital tubercle and early urethral development. Read more about Hypospadias and genes related to genital tubercle and early urethral development.
Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. Read more about Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.
Stage I testicular seminoma: a SEER analysis of contemporary adjuvant radiotherapy trends. Read more about Stage I testicular seminoma: a SEER analysis of contemporary adjuvant radiotherapy trends.
Men with low preoperative sexual function may benefit from nerve sparing radical prostatectomy. Read more about Men with low preoperative sexual function may benefit from nerve sparing radical prostatectomy.
Prostate specific antigen best practice statement: 2009 update. Read more about Prostate specific antigen best practice statement: 2009 update.
Diacylglycerol kinase K variants impact hypospadias in a California study population. Read more about Diacylglycerol kinase K variants impact hypospadias in a California study population.
Transcript levels of androgen receptor variant AR-V1 or AR-V7 do not predict recurrence in patients with prostate cancer at indeterminate risk for progression. Read more about Transcript levels of androgen receptor variant AR-V1 or AR-V7 do not predict recurrence in patients with prostate cancer at indeterminate risk for progression.
A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer. Read more about A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer.
Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346). Read more about Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346).
